
Topic: Medical: Cancer
The new items published under this topic are as follows.
New nonprofit website created by volunteers takes visitors on journey through childhood cancer travel challenges.
Posted by
compasstocare
on
Monday, December 05, 2011
Dr. Isaac Eliaz discusses the principles of integrative medicine in oncology and shares the latest research on the role of Modified Citrus Pectin (MCP) in the treatment of cancer at an international oncology conference in Rhodes, Greece.
Posted by
dreliaz
on
Tuesday, October 11, 2011
SAN FRANCISCO, CA – Dr. Steve Coats, Director of Oncology Research at MedImmune, will give a presentation at the 2nd Annual Cancer Targets and Therapeutics Conference, part of the 6th Modern Drug Discovery and Development Summit, held in San Francisco, CA, Oct. 20-22, 2010 by GTCbio.
Posted by
raniah@gtcbio.com
on
Wednesday, August 25, 2010
Contact: Genae Girard FOR IMMEDIATE RELEASE
Phone: (512) 796-1618
Email: Info@OffTheRackBook.com
Website: www.OffTheRackBook.com
NEW BREAST CANCER BOOK OFFERS HUMOR FILLED LOOK AT BEING THIRTY-SOMETHING, SINGLE AND GETTING THROUGH DIAGNOSIS
Posted by
GGirard
on
Wednesday, March 24, 2010
Many of you may be gawking at the recent headline and squirming at the very remote possibility that the folic acid and B-12 vitamin that you are taking may be the single cause of your possibly developing lung cancer. Let’s decipher the recent study that has once again caused chaos as the medical and nutritional world bunt heads.
Posted by
zinakroner
on
Thursday, November 19, 2009
Two moms, from opposite ends of the country who have yet to meet, work diligently to end brain tumors.
Posted by
dnl1231
on
Wednesday, October 21, 2009
CIG Media Group is proud to release the Proceedings of the Leukemia 2008 Fourth International Conference under our Clinical Lymphoma, Myeloma & Leukemia brand and in partnership with M. D. Anderson Cancer Center.
Posted by
cigjournals.com
on
Thursday, October 01, 2009
Insights Reveal Traditional Managed Care Model for Oncology Becoming Obsolete
Posted by
radicalgrp
on
Wednesday, July 08, 2009
Weekly tablet delivers major new benefits for patients, doctors and payors: avoiding the need for burdensome and costly infusions and related infection risks; weekly tablet dosing offers potential for better safety and side effect profile of a ‘gold standard’ oncology drug.
“The economic and treatment benefits of Orazol™ will be felt widely in the clinician and patient communities,” says Merrion Pharmaceuticals CEO, John Lynch. “No longer will costly, rigid and potentially unhealthy infusions dictate treatment decisions but instead Orazol™ opens the potential for doctors to treat more patients, more efficiently while limiting adverse impact on the patients’ quality of life.”
Posted by
jwynohradnyk
on
Tuesday, June 23, 2009
cancereducation.com announces the release of 5 new, oncology-focused multimedia programs to its site
Posted by
cancereducation
on
Wednesday, April 29, 2009